An interventional study of Bupivacaine Hydrochloride in Inguinal Hernia, sponsored by Ataturk University. Completed at 1 site in Turkey. Open to participants aged 1 Year to 8 Years. Per ClinicalTrials.gov, last updated 2022-11-16.
Sponsored by Ataturk University · Not applicable, Interventional, and Treatment
In patients undergoing lower abdominal surgery, postoperative pain management is frequently provided with systemic opioids use or neuraxial methods. Ultrasound-guided TFP block is the preferred method to reduce the use of opioids and systemic analgesics for postoperative pain management. TFP block provides anesthesia and analgesia in the inguinal region by blocking the ilioinguinal and iliohypogastric nerves.
In this study, we aimed to evaluate the effects of ultrasound-guided TFP Block on postoperative pain scores in pediatric lower abdominal surgery.
1,096 studies on the registry are indexed under Hernia; 132 are open to participants now.
This study's enrollment of 60 is below the median of 80 across 739 interventional studies indexed under Hernia.
Browse Hernia studies →Ataturk University is the lead sponsor of 442 studies on the registry; 121 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Transversalis fascia plane block, before the surgical procedure.
Drug: Bupivacaine Hydrochloride
Ultrasound-guided Transversalis Fascia Plane Block with 0.5 ml/kg %0.25 bupivacaine
Pain Score
Pain will be evaluated with a FLACC (Face, Legs, Activity, Cry, Consolability) score of 0-10 (0= no pain and 10= worst pain)
Time frame: Postoperative first 24 hours
Additional Analgesic
Additional Analgesic consumption during postoperative 24 hours
Time frame: Postoperative first 24 hours
This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ataturk University